Responses to the First Radioactive Iodine Treatment After Targeted Therapy for Aggressive Papillary Thyroid Cancers

Introduction: Tall cell variant (TCV) and columnar cell variant (CCV) are aggressive variants of papillary thyroid cancer (PTC) and they are overrepresented in radioactive iodine (RAI) refractory cases. Studies have reported using BRAF and/or MEK inhibitors to restore iodine avidity in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Soe, Myat Han, Chiang, Janet, Kang, Hyunseok, Liu, Chienying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090130/
http://dx.doi.org/10.1210/jendso/bvab048.1836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090130/
http://dx.doi.org/10.1210/jendso/bvab048.1836

Ejemplares similares